EPISODE · May 10, 2026 · 19 MIN
ORBITA CTO: The Sham-Controlled Trial That Shook CTO-PCI
from The IC Chat · host asper1971
In this episode host Ashish Pershad reviews the ORBITA CTO randomized, double-blind, sham-controlled trial that compared CTO-PCI to a placebo procedure, explaining the rigorous design, patient selection, masking methods, and statistical approach. Pershad summarizes the results showing significant symptom improvement with CTO-PCI, discusses clinical implications—blinding, careful case selection, and specialist referral—and outlines how this trial advances evidence for procedural interventions for patients with stable angina.
What this episode covers
In this episode host Ashish Pershad reviews the ORBITA CTO randomized, double-blind, sham-controlled trial that compared CTO-PCI to a placebo procedure, explaining the rigorous design, patient selection, masking methods, and statistical approach. Pershad summarizes the results showing significant symptom improvement with CTO-PCI, discusses clinical implications—blinding, careful case selection, and specialist referral—and outlines how this trial advances evidence for procedural interventions for patients with stable angina.
NOW PLAYING
ORBITA CTO: The Sham-Controlled Trial That Shook CTO-PCI
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.